REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients.
Bishop CW, Ashfaq A, Melnick JZ, Vazquez-Escarpanter E, Fialkow JA, Strugnell SA, Choe J, Kalantar-Zadeh K, Federman NC, Ng D, Adams JS.
Bishop CW, et al. Among authors: ng d.
Nutrition. 2023 Mar;107:111899. doi: 10.1016/j.nut.2022.111899. Epub 2022 Nov 7.
Nutrition. 2023.
PMID: 36529089
Free PMC article.
Clinical Trial.
The average age was 43 y (range 18-71), 59% were women. The mean baseline 25D was 37 1 (SE) ng/mL. In the full analysis set (FAS), 81% of patients in the ERC group achieved 25D levels of 50 ng/mL versus 15% in the placebo group (P < 0.0001). ...In the PP populati
…
The average age was 43 y (range 18-71), 59% were women. The mean baseline 25D was 37 1 (SE) ng/mL. In the full analysis set (FAS), 81 …